放线菌素D为临床重要抗癌药之一。单独应用或与其他方法联合应用,对绒癌和肾母细胞瘤均有一定效果。虽然它抗瘤谱较窄,但过去试验大都在应用新技术前的1950年前完成,且样品不纯,自1950年进入临床应用后又于1962和1972年相继报告对绒癌和多发性出血性肉瘤具有显著疗效,目前有必要对它作进一步的评价。 Actinomycin D is one of the clinically important anti-cancer drugs. Applied alone or in combination with other methods, on choriocarcinoma and Wilms tumor have some effect. Although its anti-tumor spectrum is narrow, most of the previous experiments were completed before 1950, and the samples were impure. Since entering clinical application in 1950, they were successively reported on choriocarcinoma and multiple bleeds in 1962 and 1972 respectively Sex sarcoma has a significant effect, it is necessary to make further evaluation of it.